euCan You Buy Neuralink Stock? Human Trials Approved for Elon Musk’s Brain Chip
Key takeaways
- Neuralink is a key company in the brain-computer interface (BCI) space
- Musk underestimated the time to market (big surprise), but we’re getting closer
- The U.S. Food and Drug Administration (FDA) has issued approval for human testing
Elon Musk’s Neuralink is the scientific development everyone’s waiting for. And we’re not the only ones who see the tech’s potential: The U.S. Food and Drug Administration (FDA) does, too. Let’s find out what’s happening.
Tech has been a thrilling sector to invest in over recent years, so you’re not alone if you want to dive in. Q.ai’s Emerging Tech Kit provides a revolutionary way to add tech to your portfolio, using AI to make weekly predictions before automatically rebalancing your portfolio for you. The Kit focuses on different tech categories, ensuring that you’re diversified with a mix of exciting developments.
Download Q.ai today for access to AI-powered investment strategies.
What is Neuralink?
We all know Elon Musk for Tesla and SpaceX. But he’s also developing something that’s intrigued the scientific, medical, and investment worlds.
Musk founded Neuralink in 2016, but this company focuses on brains, not blasting into space or electric cars. Neuralink is developing the Link, a brain implant that interfaces with external technology. That means if you have the chip, you can control compatible technology with your thoughts.
The tech could improve the lives of people with severe paralysis and muscle control issues, such as those with ALS and muscular dystrophy. Texting loved ones and simple things like choosing what to watch on Netflix with the power of the mind can restore a feeling of independence.
Pretty cool, huh?
Still, while it sounds revolutionary, it’s not the only brain chip tech. Synchron and Lausanne University are working on creating their respective brain interfaces to transform the lives of people with disabilities. They’ve recently published groundbreaking research in JAMA Neurology and Nature.
What’s happening with Neuralink?
Musk greatly overestimated the speed at which he could take Neuralink to market, originally claiming he’d implant chips in humans by 2020. Medical research is subject to extensive safety and ethical guidelines, with many devices spending up to seven years in clinical trials. Even one of the richest men in the world can’t circumvent FDA guidelines.
So, people have been waiting with bated breath for Neuralink to enter the human testing phase. Thursday brought that long-awaited news: human testing for Neuralink has finally received FDA approval.
For now, we don’t have any more news about when recruiting will start or the extent of the trial, but it’s promising news for the company.
While Neuralink has experienced several issues and controversies over the years, maybe it’s time for the exciting developments we’ve been waiting for.
The bottom line
This news may have you pondering how you can add the Neuralink stock to your portfolio. As Neuralink isn’t publicly listed, its stocks aren’t available for general purchase. Yet.
Luckily, you can invest in many other types of cutting-edge tech with Q.ai’s Emerging Tech Kit. It’s a great way to get groundbreaking assets into your portfolio, with AI finding the most promising picks and rebalancing them every week.
Download Q.ai today for access to AI-powered investment strategies.
